|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The PREMIER study: a multicenter, randomized, doubleblindclinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressiverheumatoid arthritis who had not had previous methotrexate treattnent 显示文摘 | Breedveld FC Weisman MH Kavanaugh AF | 2006 | Arthritis Rheum2006，54，1： | 1 |
| 2 | Acute nonlymphocytic leukemia after treatment of systemic lupus erythematosus with immunosuppressive agents 显示文摘 | Vaquez S Kavanaugh AF Schneider NR | 1992 | J Rheumatol1992，19，： | 1 |
| 3 | Radiogrphic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial显示文摘 | Keystone EC Kavanaugh AF Sharp JT | 2004 | Arthrtis Rheum2004，50，5： | 1 |
| 4 | The PREMIER study: a muhicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment 显示文摘 | Breedveld FC Weisman MH Kavanaugh AF | 2006 | Arthrtis Rheum2006，54，1： | 1 |
| 5 | The role of interleukin-1 in bone resorption in rheumatoid arthritis显示文摘 | Strand V Kavanaugh AF | 2004 | Rheumatology2004，43，3： | 1 |
| 6 | The problem of choice : current biologic agents and future prospects in RA 显示文摘 | Choy EH Kavanaugh AF Jones SA | 2013 | Nat Rev Rheumatol2013，9，3： | 1 |
| 7 | The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment 显示文摘 | BREEDVELD FC WEISMAN MH KAVANAUGH AF | 2006 | Arthritis Rheum2006，54，1： | 1 |
| 8 | Acute nonlymphocytic leukemia after treatment of systemic lupuserthematosus with immunosupperessive agents显示文摘 | Vasquez S Kavanaugh AF Schneider NR | 1992 | J Rheumatol1992，19，4： | 1 |
| 9 | Immunoglobulin deftciencysyndromes and therapy显示文摘 | Huston DP Kavanaugh AF Rohane PW | 2008 | J Allergy Clin Immunol2008，87，： | 1 |
| 10 | The role of interleukin-1 in bone resorption in rheumatoid arthritis 显示文摘 | Strand V Kavanaugh AF | 2004 | Rheumatology (Oxford)2004，43，13： | 1 |
| 11 | Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule-1 (ICAM-1)显示文摘 | Kavanaugh AF Davis LS Nichols LA | 1994 | Arthritis Rheum1994，37，： | 1 |
| 12 | The role of interleukin-1 in bone resorption in rheumatoid arthritis显示文摘 | Strand V Kavanaugh AF | | 0，，3： | 1 |
| 13 | The PREMIER study:A multicenter,Randomized,double-blind clinical trail of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early,aggressive rheumatoid arthritis who had not had previous methotrexate treatment显示文摘 | Breedveld FC Weisman MH Kavanaugh AF | 2006 | Arthritis Rheam2006，54，1： | 1 |
| 14 | The PREMIER study:a multicenter,randomized,double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early,aggressive rheumatoid arthritis who have not had previous methotrexate treatment显示文摘 | Breedveld FC Kavanaugh AF Cohen SB | 2006 | Arthritis Rheum2006，54，1： | 1 |
| 15 | The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment 显示文摘 | Breedveld FC Weisman MH Kavanaugh AF | 2006 | Arthritis Rheum2006，54，1： | 1 |
| 16 | Immunoglobulin deficiency syndromes and therapy显示文摘 | Huston DP Kavanaugh AF Rohane PW | 1991 | J Allergy Clin Immunol1991，87，： | 1 |
| 17 | Adalimumab plus methotrexate versus methotrexate or adalimumab alone in methotrexate-nave patients with early aggressive rheumatoid arthritis:results of the PREMIER study显示文摘 | Weisman MH Kavanaugh AF | 2006 | Arthritis Rheum2006，54，1： | 1 |
| 18 | Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial 显示文摘 | Keystone EC Kavanaugh AF Sharp JT | 2004 | Arthritis Rheum2004，50，5： | 1 |
| 19 | The role ofinterleukin-1 in bone resorption in rheumatoid arthritis 显示文摘 | Strand V Kavanaugh AF | 2004 | Rheumatology ( Oxford )2004，43，3： | 1 |
| 20 | The PREMIER study : a muhicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment 显示文摘 | Breedveld FC Weisman MH Kavanaugh AF | 2006 | Arthritis Rheum2006，54，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员